HEAD NECK CANCER
Clinical trials for HEAD NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new HEAD NECK CANCER trials appear
Sign up with your email to follow new studies for HEAD NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy offers hope for head and neck cancer patients who Can't take standard chemo
Disease control OngoingThis phase 2 trial tests a weekly combination of two chemotherapy drugs (carboplatin and paclitaxel) plus the immunotherapy pembrolizumab in 31 patients with metastatic head and neck cancer who cannot receive the standard drug 5-fluorouracil. The goal is to see if this regimen sh…
Matched conditions: HEAD NECK CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug cocktail targets tough cancers in early trial
Disease control TerminatedThis early-phase study tests a combination of two targeted drugs, palbociclib and gedatolisib, in people with advanced lung, pancreatic, head & neck, or other solid tumors that have stopped responding to standard treatments. The main goal is to find the safest dose and look for e…
Matched conditions: HEAD NECK CANCER
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Radiation's hidden toll: study tracks Long-Term dental damage in cancer patients
Knowledge-focused OngoingThis study follows 100 head and neck cancer patients receiving standard radiotherapy to see how their teeth, gums, and saliva change over time. Researchers measure gum health, tooth condition, and quality of life before and after treatment. The goal is to better understand these …
Matched conditions: HEAD NECK CANCER
Sponsor: Ain Shams University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC